Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in LRMR — Larimar Therapeutics, Inc.

CIK 80255 BALTIMORE, MD
Back to LRMR Full portfolio

Position in LRMR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$166,618
+$10,162 QoQ
Shares Held
54,629
+57.1% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 163 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. LRMR ranks #261 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in LRMR

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $166,618 54,629
2026-03-31 $156,456 34,768
2025-12-31 $110,520 29,008
2025-09-30 $74,193 22,970
2025-06-30 $61,559 21,301
2025-03-31 $35,066 16,310
2024-12-31 $59,799 15,452
2024-09-30 $88,163 13,460
2024-06-30 $97,585 13,460